Vesey Street Capital Partners L.L.C. Buys New Stake in AirSculpt Technologies, Inc. $AIRS

Vesey Street Capital Partners L.L.C. bought a new position in shares of AirSculpt Technologies, Inc. (NASDAQ:AIRS) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 30,324,180 shares of the company’s stock, valued at approximately $136,458,810. AirSculpt Technologies comprises 0.1% of Vesey Street Capital Partners L.L.C.’s portfolio, making the stock its biggest holding. Vesey Street Capital Partners L.L.C. owned approximately 42.06% of AirSculpt Technologies as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Royal Bank of Canada increased its holdings in AirSculpt Technologies by 259.6% in the first quarter. Royal Bank of Canada now owns 9,879 shares of the company’s stock worth $28,000 after buying an additional 7,132 shares during the last quarter. Virtu Financial LLC bought a new stake in shares of AirSculpt Technologies during the 4th quarter worth approximately $30,000. Millennium Management LLC bought a new stake in shares of AirSculpt Technologies in the 4th quarter valued at $33,000. Aigen Investment Management LP bought a new position in shares of AirSculpt Technologies in the fourth quarter valued at approximately $36,000. Finally, Wells Fargo & Company MN raised its position in shares of AirSculpt Technologies by 49.9% in the fourth quarter. Wells Fargo & Company MN now owns 19,275 shares of the company’s stock valued at $38,000 after purchasing an additional 6,420 shares during the period. Institutional investors and hedge funds own 91.54% of the company’s stock.

Analyst Upgrades and Downgrades

AIRS has been the subject of several analyst reports. Leerink Partners set a $4.50 price target on shares of AirSculpt Technologies in a research report on Thursday, May 14th. Wall Street Zen downgraded AirSculpt Technologies from a “buy” rating to a “hold” rating in a report on Saturday, August 15th. Finally, Weiss Ratings raised AirSculpt Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 1st. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $4.50.

AirSculpt Technologies Stock Performance

NASDAQ AIRS traded down $0.06 during trading on Friday, reaching $2.55. The company’s stock had a trading volume of 579,083 shares, compared to its average volume of 1,625,509. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.32. AirSculpt Technologies, Inc. has a 12 month low of $1.51 and a 12 month high of $12.00. The firm has a 50 day moving average price of $4.11 and a 200 day moving average price of $3.58. The firm has a market capitalization of $183.84 million, a price-to-earnings ratio of -14.17 and a beta of 2.33.

AirSculpt Technologies (NASDAQ:AIRS) last released its quarterly earnings data on Monday, August 10th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.02 by ($0.01). AirSculpt Technologies had a negative net margin of 7.79% and a negative return on equity of 5.83%. The business had revenue of $42.90 million for the quarter, compared to analysts’ expectations of $44.14 million.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.